Curis
CRIS
#10294
Rank
โ‚น1.06 B
Marketcap
โ‚น82.29
Share price
-1.39%
Change (1 day)
-72.99%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น336.32. In 2024 the company made an earnings per share (EPS) of -โ‚น644.24 an increase over its 2023 EPS that were of -โ‚น827.52.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-50.97%
2024-โ‚น644.24-22.15%
2023-โ‚น827.52-26.17%
2022-โ‚น1,12122.3%
2021-โ‚น916.41-25.37%
2020-โ‚น1,228-30.93%
2019-โ‚น1,778-2.02%
2018-โ‚น1,814
2016-โ‚น4,124-10%
2015-โ‚น4,582138.1%
2014-โ‚น1,92440%
2013-โ‚น1,375-25%
2012-โ‚น1,83366.67%
2011-โ‚น1,100

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น157.62-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น272.17-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.99-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น218.11-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น309.75-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,030 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น129.21-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA